Wird geladen...

KRAS Alleles: The Devil Is In The Detail

KRAS is the most frequently mutated oncogene in cancer and KRAS mutation is commonly associated with poor prognosis and resistance to therapy. Since the KRAS oncoprotein is, as yet, not directly druggable, efforts to target KRAS mutant cancers focus on identifying vulnerabilities in downstream signa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends Cancer
1. Verfasser: Haigis, Kevin M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824632/
https://ncbi.nlm.nih.gov/pubmed/28958387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2017.08.006
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!